Scientific News Here S What Wall Street Expects From Boston Scientific S Earnings
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Here S What Wall Street Expects From Boston Scientific S Earnings is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Boston Scientific (BSX) reports results for the quarter ended September 2025. While this widely-known consensus ... Read More
What to Expect from Boston Scientific's Earnings
Analysts are estimating that Boston Scientific will report an earnings per share (EPS) of $0.71. Boston Scientific bulls will hope to hear the company announce they've not only beaten that estimate, ... Read More
Boston Scientific sales grow more than 20% in Street-beating Q3
Boston Scientific (NYSE: BSX) shares ticked up before hours today on third-quarter results that came in ahead of the consensus forecast. Read More
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company Boston Scientific (NYSE:BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect. Read More
Boston Scientific: Q3 Earnings Snapshot
Boston Scientific Corp. (BSX) on Wednesday reported third-quarter profit of $755 million. On a per-share basis, the ... Read More
Boston Scientific (BSX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Boston Scientific (BSX) reported $5.07 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 20.3%. EPS of $0.75 for the same period compares to $0.63 a ... Read More
Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growth
Boston Scientific Q3 revenue hit $5.07 billion, beating forecasts. The company raised its full-year guidance based on strong segment growth. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus